Search for other papers by Leanne Hodson in
Google Scholar
PubMed
Search for other papers by Fredrik Karpe in
Google Scholar
PubMed
hepatic glucose and lipid metabolism by direct and indirect mechanisms ( 1 ). For example portal insulin acts on the liver to directly activate glycogen synthesis and de novo lipogenesis (DNL) and inhibit gluconeogenesis, whilst peripherally insulin may
Search for other papers by Karim Gariani in
Google Scholar
PubMed
Diabetes Center, Faculty of Medicine, University of Geneva, Geneva, Switzerland
Search for other papers by François R Jornayvaz in
Google Scholar
PubMed
of carbohydrates leading to de novo lipogenesis) ( 2 , 13 , 23 , 24 , 25 , 26 ). Nevertheless, some endocrine diseases are also associated with NAFLD and NASH ( Table 1 ), and their pathophysiology will be discussed. Table 1 Endocrine
Search for other papers by Helle Keinicke in
Google Scholar
PubMed
Search for other papers by Gao Sun in
Google Scholar
PubMed
Search for other papers by Caroline M Junker Mentzel in
Google Scholar
PubMed
Search for other papers by Merete Fredholm in
Google Scholar
PubMed
Search for other papers by Linu Mary John in
Google Scholar
PubMed
Search for other papers by Birgitte Andersen in
Google Scholar
PubMed
Search for other papers by Kirsten Raun in
Google Scholar
PubMed
Search for other papers by Marina Kjaergaard in
Google Scholar
PubMed
. ( https://doi.org/10.1016/j.cell.2005.12.022 ) 38 Postic C Girard J . Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice . Journal of Clinical Investigation 2008
Search for other papers by Yu Lin in
Google Scholar
PubMed
Search for other papers by Yingying Zhang in
Google Scholar
PubMed
Search for other papers by Lei Xu in
Google Scholar
PubMed
Search for other papers by Wei Long in
Google Scholar
PubMed
Search for other papers by Chunjian Shan in
Google Scholar
PubMed
Search for other papers by Hongjuan Ding in
Google Scholar
PubMed
Search for other papers by Lianghui You in
Google Scholar
PubMed
Search for other papers by Chun Zhao in
Google Scholar
PubMed
Search for other papers by Zhonghua Shi in
Google Scholar
PubMed
novo lipogenesis ( 21 ). Results of microarray analysis showed that pathways associated with pyruvate metabolism and TCA cycle were down-regulated, meaning that the de novo lipogenesis is suppressed, which in turn leads to the decrease of fat
Department of Nutrition, School of Public Health, Sun Yat-Sen University, Guangzhou, People’s Republic of China
Search for other papers by Xu Chen in
Google Scholar
PubMed
Search for other papers by Yi Tang in
Google Scholar
PubMed
Search for other papers by Shen Chen in
Google Scholar
PubMed
Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Guangzhou, People’s Republic of China
Search for other papers by Wenhua Ling in
Google Scholar
PubMed
Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Guangzhou, People’s Republic of China
Search for other papers by Qing Wang in
Google Scholar
PubMed
hepatic de novo lipogenesis and may serve as a biomarker of NAFLD progression ( 21 ). Here, we combined two datasets from GSE database and found that hepatic IGFBP-2 expression as a hub gene was also reversely associated with steatosis and serum ALT
Search for other papers by Jana Ernst in
Google Scholar
PubMed
Search for other papers by Katharina Gert in
Google Scholar
PubMed
Search for other papers by Frank Bernhard Kraus in
Google Scholar
PubMed
Search for other papers by Ulrike Elisabeth Rolle-Kampczyk in
Google Scholar
PubMed
Search for other papers by Martin Wabitsch in
Google Scholar
PubMed
Search for other papers by Faramarz Dehghani in
Google Scholar
PubMed
Search for other papers by Kristina Schaedlich in
Google Scholar
PubMed
an enzyme machinery enabling them for the de novo synthesis of steroid hormones from cholesterol ( 8 ). Androgenic steroids exhibit a positive gradient from blood to adipose tissue with the precursor androstenedione and dehydroepiandrosterone as
Search for other papers by Kennett Sprogøe in
Google Scholar
PubMed
Search for other papers by Eva Mortensen in
Google Scholar
PubMed
Search for other papers by David B Karpf in
Google Scholar
PubMed
Search for other papers by Jonathan A Leff in
Google Scholar
PubMed
in China Pfizer, Inc. PHA-794428 Permanently PEGylated GH Discontinued Novo Nordisk A/S NNCl126-0083 Permanently PEGylated GH Discontinued Ambrx, Inc. ARX201 Permanently PEGylated and mutated GH Discontinued Teva
Search for other papers by Huixing Liu in
Google Scholar
PubMed
Search for other papers by Daoquan Peng in
Google Scholar
PubMed
hypothyroidism. The altered functions are labeled in the presence of hypothyroidism. Red arrows mark actions of declined TH, and blue arrows mark actions of elevated TSH. TH decreases in hypothyroidism and then de novo lipogenesis (DNL) and the activity of HMG
Search for other papers by Peter Wolf in
Google Scholar
PubMed
Search for other papers by Yvonne Winhofer in
Google Scholar
PubMed
High Field MR Centre, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria
Search for other papers by Martin Krššák in
Google Scholar
PubMed
Search for other papers by Michael Krebs in
Google Scholar
PubMed
hyperlipidemia, hyperinsulinemia and hyperglycemia ( 71 ). It remains to be investigated whether this is due to increased lipid oxidation promoted by GH and IGF-1 or due to alterations in hepatic lipid metabolism, i.e. de novo lipogenesis and lipolysis
Search for other papers by Anastasia P Athanasoulia-Kaspar in
Google Scholar
PubMed
Search for other papers by Kathrin H Popp in
Google Scholar
PubMed
Search for other papers by Gunter Karl Stalla in
Google Scholar
PubMed
characterized by the maladaptive nature of the preoccupations and the inability of the subject to control these urges, and they mainly have a de novo onset after the initiation of the DA on the basis of a negative psychiatric history. Whereas the overall